ORD

Dec 21 2024HEALTH

Sleep Apnoea Treatment Gets New Drug Approval

Big news! The US Food and Drug Administration has given the go-ahead for Eli Lilly's new drug, Zepbound, to treat adults with both sleep apnoea and obesity. This could be a game-changer for the company, as it looks to expand its successful weight-loss drug business. The drug was shown to significant

reading time less than a minute
Dec 21 2024HEALTH

Smart Models, Better Cancer Care

Doctors traditionally use tricky rule-based systems to review medical reports, and even though these methods work, they take a lot of time and can lead to errors, especially with unstructured data like doctors' notes. Enter large language models (LLMs), which are making waves in the medical field. T

reading time less than a minute
Dec 21 2024SPORTS

NFL's Rare Fair-Catch Kick: A Halftime Surprise

Ever heard of a fair-catch free kick in football? It's a rare thing, used only a handful of times in hundreds of games. Before last night, only one team had successfully pulled it off in the last 48 years. That's right, just one! Out of 16 attempts, only one succeeded. But last night, the Chargers'

reading time less than a minute
Dec 21 2024BUSINESS

Chongqing's Path to Better Economic Development: A Different Look

What makes a region develop economically in a high-quality way? This question is explored in a study that focuses on Chongqing's "One District, Two Groups" initiative from 2017 to 2021. By creating an index system with dimensions like economic vitality, coordinated growth, green development, and dig

reading time less than a minute
Dec 21 2024HEALTH

Staying on Track: Mobile Health and Antiretroviral Therapy

These days, mobile health or mHealth technologies are super popular. But guess what? We don't know much about how these apps and tools help people with HIV who also deal with substance use disorders. The big question is: Which mHealth system features can really make a difference in keeping these fol

reading time less than a minute
Dec 20 2024BUSINESS

Novo Nordisk's New Weight-Loss Drug Fails to Impress Investors

Novo Nordisk, a big player in Europe's pharma scene, saw its shares take a huge hit on Friday. Why? Their latest weight-loss drug, CagriSema, didn't meet expectations. The drug helped patients lose about 22. 7% of their body weight in late-stage trials, but that was barely better than Eli Lilly's ri

reading time less than a minute
Dec 20 2024ENVIRONMENT

Natural Disasters Strike Hard in 2024

In 2024, natural disasters caused extensive damage and claimed hundreds of lives worldwide. The year started with powerful tornadoes sweeping through the United States, followed by devastating earthquakes and floods in Asia and the Middle East. Summer brought intense heat waves and a series of hurri

reading time less than a minute
Dec 20 2024HEALTH

Apps for Spinal Cord Injury Care: A Mobile Search

Mobile technology has been a game-changer in healthcare, especially for folks with long-term health issues. But when it comes to spinal cord injury (SCI), apps that offer self-management support haven't gotten much attention. We don't know much about what's out there and what's good. So, let's dive

reading time less than a minute
Dec 20 2024HEALTH

Who's in Charge? Identifying Daily Care Providers in Hospitals

You might think all doctors are the same, but that's not true. Some are better than others, and this can affect how well patients get better. Usually, researchers don't consider who's taking care of a patient when they study healthcare. This is a missed opportunity because different doctors can lead

reading time less than a minute
Dec 19 2024HEALTH

Snoring Kids: Impact on Brain Functions and Daily Life

Ever wondered how snoring affects kids? It turns out, mild sleep-disordered breathing (mSDB) can cause real problems. Research shows it's linked to both behavior issues and a lower quality of life (QOL). But there's more to explore. How do symptoms and daily life impact a child's ability to think an

reading time less than a minute